Publication Details

Category Text Publication
Reference Category Journals
DOI 10.1093/intimm/dxp117
Title (Primary) Administration of IL-23 engages innate and adaptive immune mechanisms during fungal infection
Author Kleinschek, M.A.; Müller, U.; Schütze, N.; Sabat, N.; Straubinger, R.K.; Blumenschein, W.M.; McClanahan, T.; Kastelein, R.A.; Alber, G.
Source Titel International Immunology
Year 2010
Department IMMU
Volume 22
Issue 2
Page From 81
Page To 90
Language englisch
Keywords Cryptococcus; cytokine; gene-deficient mice; infection, Th17
Abstract IL-23 is a key cytokine in promotion of chronic inflammation. Here, we address if its pro-inflammatory potential can be harnessed to protect against chronic cryptococcosis. Mice were infected with Cryptococcus neoformans and treated with recombinant IL-23. Administration of IL-23 led to prolonged survival and reduced fungal burden but was inferior to IL-12 treatment. Independent of endogenous IL-23/IL-12, IL-23 treatment induced an altered cytokine profile accompanied by marked changes in composition of the inflammatory infiltrate characterized by T cell and dendritic cell recruitment. Although IL-23 induced hallmarks of the Th17 pathway, also non-T cells produced IL-17A and IL-22. IL-23 treatment of T-cell-deficient mice resulted in increased IL-17A and IL-22 production and modulation of the cellular response at the site of infection with elevated expression of CD86 on macrophages. Our data show that IL-23 treatment induces innate and adaptive tissue inflammation with limited impact on resistance to chronic cryptococcosis.
Kleinschek, M.A., Müller, U., Schütze, N., Sabat, N., Straubinger, R.K., Blumenschein, W.M., McClanahan, T., Kastelein, R.A., Alber, G. (2010):
Administration of IL-23 engages innate and adaptive immune mechanisms during fungal infection
Int. Immunol. 22 (2), 81 - 90 10.1093/intimm/dxp117